AUPH

Bullish

Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has successfully completed its tender offer for Kezar Life Sciences, with 80.24% of Kezar's outstanding sh...

citybiz 6 hours ago 0

Bearish

FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’

This article discusses the ongoing turmoil at the FDA, which has now impacted Aurinia Pharma. A lawsuit has been filed against a former FDA drug revie...

MSN 3 weeks ago 0